September 14, 2026
CellCarta is a global CRO that brings genomics, histopathology, immunology, and proteomics together, giving you the scientific depth, operational scale, and hands-on partnership your program deserves from discovery through phase III trials and CDx.
In this brochure, learn more about CellCarta's biomarker capabilities, logistics support, regulatory infrastructure, and scientific expertise built to support your program through every phase of development, including CDx.
